Back to catalogue
IIG
Intuitive Investments Group PLC
300/1000 Overall fit
AI beneficiary 35% 35
Operating leverage 25% 28
Valuation 25% 25
Downside protection 15% 32
First-pass take
Closed-end life sciences fund with minimal AI thesis—only PneumoWave shows explicit AI (software); no stated strategy around AI/ML trends. NAV fell 10.6% YoY; unrealised investment losses £1.5m; quoted holdings collapsed 59%. Micro-cap (£12.9m) concentrated in Sanondaf (49%) facing post-COVID revenue decline and acquisition integration risk. No share-price data; cash eroding.
Flags
no-valuation-dataloss-makingmicro-capconcentratedportfolio-deteriorationsmall-cap-healthcare-headwindsintegration-riskcash-burn